Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche Holding AG (OTCQX International Premier:RHHVF)

250.18
Delayed Data
As of Sep 29
 -2.64 / -1.04%
Today’s Change
238.95
Today|||52-Week Range
281.05
-8.71%
Year-to-Date
3 Critical FDA Decisions You Can't Afford to Miss
Sep 27 / MotleyFool.com - Paid Partner Content
Why Array BioPharma Inc Is Surging Today
Sep 26 / MotleyFool.com - Paid Partner Content
Mairs and Power Buys Walt Disney, Exits Baxalta
Sep 27 / GuruFocus News - Paid Partner Content
BioLineRx Begins Trial on BL-8040/ Keytruda Combination
Sep 21 / Zacks.com - Paid Partner Content
Array (ARRY) Hits 52-Week High on Positive Phase III Data
Sep 27 / Zacks.com - Paid Partner Content
Puma (PBYI) Neratinib's NDA Accepted for Review, Stock Up
Sep 21 / Zacks.com - Paid Partner Content
Bristol, Nektar Research Pact Aims to Boost Efficacy of Cancer Immunotherapy
Sep 27 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close252.82
Today’s open249.02
Day’s range247.87 - 250.33
Volume335
Average volume (3 months)5,378
Market cap$175.8B
Dividend yield3.21%
Data as of 09/29/2016

Growth & Valuation

Earnings growth (last year)-9.95%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-3.56%
P/E ratio--
Price/Sales4.76
Price/Book10.17

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$50.0B
Annual profit (last year)$9.2B
Net profit margin18.41%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Severin Schwan
COO-
Roche Diagnostics Division
Roland Diggelmann
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts

Search for Jobs